Related Experiment Video
Updated: Jul 15, 2025

18F-Labeling of Radiotracers Functionalized with a Silicon Fluoride Acceptor SiFA for Positron Emission Tomography
Published on: January 11, 2020
Indole-Based and Cyclopentenylindole-Based Analogues Containing Fluorine Group as Potential 18F-Labeled Positron
Runkai Yin1, Kelly X Huang1, Lina A Huang1
1Department of Translational Research & Cellular Therapeutics, Arthur Riggs Diabetes and Metabolism Research Institute, Beckman Research Institute of the City of Hope, Duarte, CA 91010, USA.
Abstract:
Recently, growing evidence of the relationship between G-protein coupled receptor 44 (GPR44) and the inflammation-cancer system has garnered tremendous interest, while the exact role of GPR44 has not been fully elucidated. Currently, there is a strong and urgent need for the development of non-invasive in vivo GPR44 positron emission tomography (PET) radiotracers that can be used to aid the exploration of the relationship between inflammation and tumor biologic behavior. Accordingly, the choosing and radiolabeling of existing GPR44 antagonists containing a fluorine group could serve as a viable method to accelerate PET tracers development for in vivo imaging to this purpose. The present study aims to evaluate published (2000-present) indole-based and cyclopentenyl-indole-based analogues of the GPR44 antagonist to guide the development of fluorine-18 labeled PET tracers that can accurately detect inflammatory processes. The selected analogues contained a crucial fluorine nuclide and were characterized for various properties including binding affinity, selectivity, and pharmacokinetic and metabolic profile. Overall, 26 compounds with favorable to strong binding properties were identified. This review highlights the potential of GPR44 analogues for the development of PET tracers to study inflammation and cancer development and ultimately guide the development of targeted clinical therapies.
Insights
Researchers reviewed G-protein coupled receptor 44 (GPR44) antagonists to develop fluorine-18 labeled PET tracers. These tracers can help visualize inflammation and cancer, aiding targeted therapy development.
Area of Science:
- Oncology
- Radiochemistry
- Pharmacology
Background:
- Growing evidence links G-protein coupled receptor 44 (GPR44) to inflammation and cancer.
- The precise role of GPR44 in tumor biology requires further elucidation.
- There is a need for non-invasive imaging tools to study GPR44's role in vivo.
Purpose of the Study:
- To evaluate indole-based and cyclopentenyl-indole-based GPR44 antagonists for developing fluorine-18 labeled PET tracers.
- To guide the development of PET tracers for visualizing inflammatory processes.
- To identify compounds suitable for in vivo imaging of inflammation and cancer.
Main Methods:
- Systematic review of published GPR44 antagonists (2000-present).
- Focus on indole and cyclopentenyl-indole analogues containing fluorine.
- Evaluation of binding affinity, selectivity, and pharmacokinetic/metabolic profiles.
Main Results:
- Identified 26 GPR44 analogues with favorable to strong binding properties.
- Selected analogues contain a fluorine nuclide suitable for radiolabeling.
- Characterization data provides a basis for PET tracer development.
Conclusions:
- GPR44 analogues show significant potential for developing PET tracers.
- Fluorine-18 labeled GPR44 tracers can aid in studying inflammation and cancer.
- This research can guide the development of targeted clinical therapies for cancer.
Related Concept Videos
Positron Emission Tomography
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET
![Microwave-assisted One-pot Synthesis of N-succinimidyl-4-[18F]fluorobenzoate [18F]SFB](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F2755.jpg&w=3840&q=50)
![Automated Radiochemical Synthesis of [18F]3F4AP: A Novel PET Tracer for Imaging Demyelinating Diseases](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F55537.jpg&w=3840&q=50)